IPHA
Price
$1.70
Change
-$0.06 (-3.41%)
Updated
Dec 24 closing price
Capitalization
165.47M
83 days until earnings call
Intraday BUY SELL Signals
VALN
Price
$8.48
Change
+$0.12 (+1.44%)
Updated
Dec 24 closing price
Capitalization
743.3M
83 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

IPHA vs VALN

Header iconIPHA vs VALN Comparison
Open Charts IPHA vs VALNBanner chart's image
Innate Pharma SA
Price$1.70
Change-$0.06 (-3.41%)
Volume$37.42K
Capitalization165.47M
Valneva SE
Price$8.48
Change+$0.12 (+1.44%)
Volume$3.5K
Capitalization743.3M
IPHA vs VALN Comparison Chart in %
IPHA
Daily Signal:
Gain/Loss:
VALN
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
IPHA vs. VALN commentary
Dec 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IPHA is a Buy and VALN is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 26, 2025
Stock price -- (IPHA: $1.70 vs. VALN: $8.48)
Brand notoriety: IPHA and VALN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IPHA: 15% vs. VALN: 15%
Market capitalization -- IPHA: $165.47M vs. VALN: $743.3M
IPHA [@Biotechnology] is valued at $165.47M. VALN’s [@Biotechnology] market capitalization is $743.3M. The market cap for tickers in the [@Biotechnology] industry ranges from $117.47B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IPHA’s FA Score shows that 1 FA rating(s) are green whileVALN’s FA Score has 1 green FA rating(s).

  • IPHA’s FA Score: 1 green, 4 red.
  • VALN’s FA Score: 1 green, 4 red.
According to our system of comparison, VALN is a better buy in the long-term than IPHA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IPHA’s TA Score shows that 3 TA indicator(s) are bullish while VALN’s TA Score has 5 bullish TA indicator(s).

  • IPHA’s TA Score: 3 bullish, 3 bearish.
  • VALN’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, VALN is a better buy in the short-term than IPHA.

Price Growth

IPHA (@Biotechnology) experienced а -6.08% price change this week, while VALN (@Biotechnology) price change was +2.97% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.88%. For the same industry, the average monthly price growth was +4.46%, and the average quarterly price growth was +55.39%.

Reported Earning Dates

IPHA is expected to report earnings on Mar 19, 2026.

VALN is expected to report earnings on Mar 19, 2026.

Industries' Descriptions

@Biotechnology (+2.88% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VALN($743M) has a higher market cap than IPHA($165M). VALN YTD gains are higher at: 94.076 vs. IPHA (-7.609).
IPHAVALNIPHA / VALN
Capitalization165M743M22%
EBITDAN/A-71.86M-
Gain YTD-7.60994.076-8%
P/E RatioN/AN/A-
RevenueN/A180M-
Total CashN/A143M-
Total DebtN/A196M-
FUNDAMENTALS RATINGS
IPHA: Fundamental Ratings
IPHA
OUTLOOK RATING
1..100
55
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
77
P/E GROWTH RATING
1..100
31
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IPHAVALN
RSI
ODDS (%)
N/A
Bullish Trend 3 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
73%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
85%
MACD
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
85%
Bullish Trend 3 days ago
77%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
83%
Advances
ODDS (%)
Bullish Trend 12 days ago
73%
Bullish Trend 16 days ago
74%
Declines
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 8 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
88%
Bullish Trend 3 days ago
79%
Aroon
ODDS (%)
N/A
Bullish Trend 3 days ago
75%
View a ticker or compare two or three
Interact to see
Advertisement
IPHA
Daily Signal:
Gain/Loss:
VALN
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IDXG1.100.02
+1.85%
Interpace Biosciences, Inc.
BPMUF63.25N/A
N/A
Basilea Pharmaceutica AG
BPXXY25.94N/A
N/A
BPER BANCA S.P.A
FOSUF0.43N/A
N/A
Fosun International, Ltd.
WRSLF0.26N/A
N/A
Winsome Resources Ltd.

IPHA and

Correlation & Price change

A.I.dvisor indicates that over the last year, IPHA has been loosely correlated with MDGL. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if IPHA jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IPHA
1D Price
Change %
IPHA100%
-3.41%
MDGL - IPHA
43%
Loosely correlated
+0.10%
APLM - IPHA
36%
Loosely correlated
+4.41%
SLNO - IPHA
34%
Loosely correlated
+0.61%
COGT - IPHA
32%
Poorly correlated
-1.10%
TNXP - IPHA
30%
Poorly correlated
+0.03%
More

VALN and

Correlation & Price change

A.I.dvisor indicates that over the last year, VALN has been loosely correlated with INRLF. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if VALN jumps, then INRLF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VALN
1D Price
Change %
VALN100%
+1.50%
INRLF - VALN
42%
Loosely correlated
N/A
ORKA - VALN
35%
Loosely correlated
+1.29%
PTCT - VALN
32%
Poorly correlated
+0.86%
ZNTL - VALN
30%
Poorly correlated
+2.22%
SYRE - VALN
29%
Poorly correlated
-0.54%
More